Skip to main content
Equibles

Caption Management, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$526,845
-$64,564 QoQ
Shares Held
478,950
+4749.1% QoQ
Ownership
0.463%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 101 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Jun 30, 2026
CallValue
$440,000
CallShares
400,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. INO ranks #55 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in INO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $526,845 478,950
2026-06-30 $440,000 400,000
2021-12-31 $748,499 150,000
2021-12-31 $591,409 118,519
2021-06-30 $926,999 100,000
2020-12-31 $1,061,999 120,000
2020-09-30 $7,534,199 649,500
2020-09-30 $985,999 85,000
2020-06-30 $13,555,849 503,000